{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:21:25Z","timestamp":1772119285512,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012269","name":"Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province","doi-asserted-by":"publisher","award":["19K09003"],"award-info":[{"award-number":["19K09003"]}],"id":[{"id":"10.13039\/501100012269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11102-022-01220-4","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T11:04:12Z","timestamp":1650625452000},"page":"496-507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Responsiveness to DDAVP in Cushing\u2019s disease is associated with USP8 mutations through enhancing AVPR1B promoter activity"],"prefix":"10.1007","volume":"25","author":[{"given":"Hiroki","family":"Shichi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9255-653X","authenticated-orcid":false,"given":"Hidenori","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Kanzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Urai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryusaku","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Kanie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Bando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genzo","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Inoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shozo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"key":"1220_CR1","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","volume":"367","author":"J Newell-Price","year":"2006","unstructured":"Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing\u2019s syndrome. Lancet 367:1605\u20131617. https:\/\/doi.org\/10.1016\/S0140-6736(06)68699-6","journal-title":"Lancet"},{"key":"1220_CR2","doi-asserted-by":"publisher","first-page":"R205","DOI":"10.1530\/EJE-16-0946","volume":"176","author":"JW Findling","year":"2017","unstructured":"Findling JW, Raff H (2017) Diagnosis of endocrine disease: differentiation of pathologic\/neoplastic hypercortisolism (Cushing\u2019s syndrome) from physiologic\/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing\u2019s syndrome). Eur J Endocrinol 176:R205\u2013R216. https:\/\/doi.org\/10.1530\/EJE-16-0946","journal-title":"Eur J Endocrinol"},{"key":"1220_CR3","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BMK, Findling JW et al (2008) The diagnosis of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:1526\u20131540. https:\/\/doi.org\/10.1210\/jc.2008-0125","journal-title":"J Clin Endocrinol Metab"},{"key":"1220_CR4","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1210\/jc.2007-2734","volume":"93","author":"BMK Biller","year":"2008","unstructured":"Biller BMK, Grossman AB, Stewart PM et al (2008) Treatment of adrenocorticotropin-dependent Cushing\u2019s syndrome: a consensus statement. J Clin Endocrinol Metab 93:2454\u20132462. https:\/\/doi.org\/10.1210\/jc.2007-2734","journal-title":"J Clin Endocrinol Metab"},{"key":"1220_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1365-2265.1993.tb00341.x","volume":"38","author":"DA Malerbi","year":"1993","unstructured":"Malerbi DA, Mendon\u00e7a BB, Liberman B et al (1993) The desmopressin stimulation test in the differential diagnosis of Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 38:463\u2013472. https:\/\/doi.org\/10.1111\/j.1365-2265.1993.tb00341.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1220_CR6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1046\/j.1365-2265.1997.1330954.x","volume":"46","author":"P Colombo","year":"1997","unstructured":"Colombo P, Passini E, Re T et al (1997) Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess. Clin Endocrinol (Oxf) 46:661\u2013668. https:\/\/doi.org\/10.1046\/j.1365-2265.1997.1330954.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1220_CR7","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1210\/jcem.81.6.8964857","volume":"81","author":"DA Malerbi","year":"1996","unstructured":"Malerbi DA, Fragoso MC, Vieira Filho AH et al (1996) Cortisol and adrenocorticotropin response to desmopressin in women with Cushing\u2019s disease compared with depressive illness. J Clin Endocrinol Metab 81:2233\u20132237. https:\/\/doi.org\/10.1210\/jcem.81.6.8964857","journal-title":"J Clin Endocrinol Metab"},{"key":"1220_CR8","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1210\/jcem.85.10.6862","volume":"85","author":"M Moro","year":"2000","unstructured":"Moro M, Putignano P, Losa M et al (2000) The desmopressin test in the differential diagnosis between Cushing\u2019s disease and pseudo-Cushing states. J Clin Endocrinol Metab 85:3569\u20133574. https:\/\/doi.org\/10.1210\/jcem.85.10.6862","journal-title":"J Clin Endocrinol Metab"},{"key":"1220_CR9","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1210\/jcem.81.5.8626831","volume":"81","author":"PL Dahia","year":"1996","unstructured":"Dahia PL, Ahmed-Shuaib A, Jacobs RA et al (1996) Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors. J Clin Endocrinol Metab 81:1768\u20131771. https:\/\/doi.org\/10.1210\/jcem.81.5.8626831","journal-title":"J Clin Endocrinol Metab"},{"key":"1220_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1046\/j.1365-2265.1998.00560.x","volume":"49","author":"Y De Keyzer","year":"1998","unstructured":"De Keyzer Y, Ren\u00e9 P, Beldjord C et al (1998) Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours. Clin Endocrinol (Oxf) 49:475\u2013482. https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00560.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1220_CR11","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1210\/jc.2013-1992","volume":"98","author":"RM Luque","year":"2013","unstructured":"Luque RM, Ib\u00e1\u00f1ez-Costa A, L\u00f3pez-S\u00e1nchez LM et al (2013) A cellular and molecular basis for the selective desmopressin-induced ACTH release in Cushing disease patients: key role of AVPR1b receptor and potential therapeutic implications. J Clin Endocrinol Metab 98:4160\u20134169. https:\/\/doi.org\/10.1210\/jc.2013-1992","journal-title":"J Clin Endocrinol Metab"},{"key":"1220_CR12","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1210\/jc.2016-2799","volume":"101","author":"DA Vassiliadi","year":"2016","unstructured":"Vassiliadi DA, Balomenaki M, Asimakopoulou A et al (2016) The desmopressin test predicts better than basal cortisol the long-term surgical outcome of Cushing\u2019s disease. J Clin Endocrinol Metab 101:4878\u20134885. https:\/\/doi.org\/10.1210\/jc.2016-2799","journal-title":"J Clin Endocrinol Metab"},{"key":"1220_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng.3166","volume":"47","author":"M Reincke","year":"2015","unstructured":"Reincke M, Sbiera S, Hayakawa A et al (2015) Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease. Nat Genet 47:31\u201338. https:\/\/doi.org\/10.1038\/ng.3166","journal-title":"Nat Genet"},{"key":"1220_CR14","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1038\/s41467-018-05275-5","volume":"9","author":"J Chen","year":"2018","unstructured":"Chen J, Jian X, Deng S et al (2018) Identification of recurrent USP48 and BRAF mutations in Cushing\u2019s disease. Nat Commun 9:3171. https:\/\/doi.org\/10.1038\/s41467-018-05275-5","journal-title":"Nat Commun"},{"key":"1220_CR15","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/neuonc\/noz109","volume":"21","author":"S Sbiera","year":"2019","unstructured":"Sbiera S, Perez-Rivas LG, Taranets L et al (2019) Driver mutations in USP8 wild-type Cushing\u2019s disease. Neuro Oncol 21:1273\u20131283. https:\/\/doi.org\/10.1093\/neuonc\/noz109","journal-title":"Neuro Oncol"},{"key":"1220_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/cr.2015.20","volume":"25","author":"Z-Y Ma","year":"2015","unstructured":"Ma Z-Y, Song Z-J, Chen J-H et al (2015) Recurrent gain-of-function USP8 mutations in Cushing\u2019s disease. Cell Res 25:306\u2013317. https:\/\/doi.org\/10.1038\/cr.2015.20","journal-title":"Cell Res"},{"key":"1220_CR17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/cen.13802","volume":"89","author":"A Albani","year":"2018","unstructured":"Albani A, P\u00e9rez-Rivas LG, Dimopoulou C et al (2018) The USP8 mutational status may predict long-term remission in patients with Cushing\u2019s disease. Clin Endocrinol (Oxf) 89:454\u2013458. https:\/\/doi.org\/10.1111\/cen.13802","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1220_CR18","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1172\/JCI60417","volume":"121","author":"H Fukuoka","year":"2011","unstructured":"Fukuoka H, Cooper O, Ben-Shlomo A et al (2011) EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas. J Clin Invest 121:4712\u20134721. https:\/\/doi.org\/10.1172\/JCI60417","journal-title":"J Clin Invest"},{"key":"1220_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000500688","volume":"110","author":"A Sesta","year":"2020","unstructured":"Sesta A, Cassarino MF, Terreni M et al (2020) Ubiquitin-specific protease 8 mutant corticotrope adenomas present unique secretory and molecular features and shed light on the role of ubiquitylation on ACTH processing. Neuroendocrinology 110:119\u2013129. https:\/\/doi.org\/10.1159\/000500688","journal-title":"Neuroendocrinology"},{"key":"1220_CR20","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1210\/jc.2018-02564","volume":"104","author":"I Weigand","year":"2019","unstructured":"Weigand I, Knobloch L, Flitsch J et al (2019) Impact of USP8 gene mutations on protein deregulation in Cushing disease. J Clin Endocrinol Metab 104:2535\u20132546. https:\/\/doi.org\/10.1210\/jc.2018-02564","journal-title":"J Clin Endocrinol Metab"},{"key":"1220_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1507\/endocrj.ej12-0299","volume":"60","author":"K Kageyama","year":"2013","unstructured":"Kageyama K, Oki Y, Sakihara S et al (2013) Evaluation of the diagnostic criteria for Cushing\u2019s disease in Japan. Endocr J 60:127\u2013135. https:\/\/doi.org\/10.1507\/endocrj.ej12-0299","journal-title":"Endocr J"},{"key":"1220_CR22","doi-asserted-by":"publisher","first-page":"E780","DOI":"10.1152\/ajpendo.2001.280.5.E780","volume":"280","author":"A Nomura","year":"2001","unstructured":"Nomura A, Iwasaki Y, Saito M et al (2001) Involvement of upstream open reading frames in regulation of rat V(1b) vasopressin receptor expression. Am J Physiol Endocrinol Metab 280:E780\u2013E787. https:\/\/doi.org\/10.1152\/ajpendo.2001.280.5.E780","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1220_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1365-2265.2011.04179.x","volume":"76","author":"F-F Wang","year":"2012","unstructured":"Wang F-F, Tang K-T, Yen Y-S et al (2012) Plasma corticotrophin response to desmopressin in patients with Cushing\u2019s disease correlates with the expression of vasopressin receptor 2, but not with that of vasopressin receptor 1 or 3, in their pituitary tumours. Clin Endocrinol (Oxf) 76:253\u2013263. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04179.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1220_CR24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1365-2265.2006.02717.x","volume":"66","author":"F Pecori Giraldi","year":"2007","unstructured":"Pecori Giraldi F, Pivonello R, Ambrogio AG et al (2007) The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing\u2019s syndrome from pseudo-Cushing\u2019s states. Clin Endocrinol (Oxf) 66:251\u2013257. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02717.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1220_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1210\/jcem.82.1.3674","volume":"82","author":"J Newell-Price","year":"1997","unstructured":"Newell-Price J, Perry L, Medbak S et al (1997) A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing\u2019s synd rome. J Clin Endocrinol Metab 82:176\u2013181. https:\/\/doi.org\/10.1210\/jcem.82.1.3674","journal-title":"J Clin Endocrinol Metab"},{"key":"1220_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1046\/j.1365-2265.2001.01260.x","volume":"54","author":"M Terzolo","year":"2001","unstructured":"Terzolo M, Reimondo G, Al\u00ec A et al (2001) The limited value of the desmopressin test in the diagnostic approach to Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 54:609\u2013616. https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01260.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1220_CR27","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s11102-016-0729-y","volume":"19","author":"M Barbot","year":"2016","unstructured":"Barbot M, Trementino L, Zilio M et al (2016) Second-line tests in the differential diagnosis of ACTH-dependent Cushing\u2019s syndrome. Pituitary 19:488\u2013495. https:\/\/doi.org\/10.1007\/s11102-016-0729-y","journal-title":"Pituitary"},{"key":"1220_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1046\/j.1365-2265.1999.00830.x","volume":"51","author":"Tsagarakis, Vasiliou, Kokkoris","year":"1999","unstructured":"Tsagarakis, Vasiliou, Kokkoris et al (1999) Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing\u2019s syndrome and simple obesity. Clin Endocrinol (Oxf) 51:473\u2013477. https:\/\/doi.org\/10.1046\/j.1365-2265.1999.00830.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1220_CR29","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/cmdc.200900409","volume":"5","author":"M Colombo","year":"2010","unstructured":"Colombo M, Vallese S, Peretto I et al (2010) Synthesis and biological evaluation of 9-Oxo-9 H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile analogues as potential inhibitors of deubiquitinating enzymes. ChemMedChem 5:552\u2013558. https:\/\/doi.org\/10.1002\/cmdc.200900409","journal-title":"ChemMedChem"},{"key":"1220_CR30","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1210\/jcem.87.4.8358","volume":"87","author":"S Tsagarakis","year":"2002","unstructured":"Tsagarakis S, Tsigos C, Vasiliou V et al (2002) The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing\u2019s syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion. J Clin Endocrinol Metab 87:1646\u20131653. https:\/\/doi.org\/10.1210\/jcem.87.4.8358","journal-title":"J Clin Endocrinol Metab"},{"key":"1220_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12929-019-0522-0","volume":"26","author":"M-J Young","year":"2019","unstructured":"Young M-J, Hsu K-C, Lin TE et al (2019) The role of ubiquitin-specific peptidases in cancer progression. J Biomed Sci 26:42. https:\/\/doi.org\/10.1186\/s12929-019-0522-0","journal-title":"J Biomed Sci"},{"key":"1220_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1677\/jme.1.01995","volume":"36","author":"S Volpi","year":"2006","unstructured":"Volpi S, Liu Y, Aguilera G (2006) Vasopressin increases GAGA binding activity to the V1b receptor promoter through transactivation of the MAP kinase pathway. J Mol Endocrinol 36:581\u2013590. https:\/\/doi.org\/10.1677\/jme.1.01995","journal-title":"J Mol Endocrinol"},{"key":"1220_CR33","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12020-018-1776-0","volume":"63","author":"M Losa","year":"2019","unstructured":"Losa M, Mortini P, Pagnano A et al (2019) Clinical characteristics and surgical outcome in USP8-mutated human adrenocorticotropic hormone-secreting pituitary adenomas. Endocrine 63:240\u2013246. https:\/\/doi.org\/10.1007\/s12020-018-1776-0","journal-title":"Endocrine"},{"key":"1220_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1530\/EJE-15-0689","volume":"174","author":"K Hayashi","year":"2016","unstructured":"Hayashi K, Inoshita N, Kawaguchi K et al (2016) The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing\u2019s disease. Eur J Endocrinol 174:213\u2013226. https:\/\/doi.org\/10.1530\/EJE-15-0689","journal-title":"Eur J Endocrinol"},{"key":"1220_CR35","doi-asserted-by":"publisher","first-page":"E997","DOI":"10.1210\/jc.2015-1453","volume":"100","author":"LG Perez-Rivas","year":"2015","unstructured":"Perez-Rivas LG, Theodoropoulou M, Ferra\u00f9 F et al (2015) The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing\u2019s disease. J Clin Endocrinol Metab 100:E997\u2013E1004. https:\/\/doi.org\/10.1210\/jc.2015-1453","journal-title":"J Clin Endocrinol Metab"},{"key":"1220_CR36","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3390\/cancers11111761","volume":"11","author":"S Sbiera","year":"2019","unstructured":"Sbiera S, Kunz M, Weigand I et al (2019) The new genetic landscape of Cushing\u2019s disease: deubiquitinases in the spotlight. Cancers (Basel) 11:1761. https:\/\/doi.org\/10.3390\/cancers11111761","journal-title":"Cancers (Basel)"},{"key":"1220_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11102-019-00973-9","volume":"22","author":"IQ Wanichi","year":"2019","unstructured":"Wanichi IQ, de Paula Mariani BM, Frassetto FP et al (2019) Cushing\u2019s disease due to somatic USP8 mutations: a systematic review and meta-analysis. Pituitary 22:435\u2013442. https:\/\/doi.org\/10.1007\/s11102-019-00973-9","journal-title":"Pituitary"},{"key":"1220_CR38","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1530\/ERC-21-0093","volume":"28","author":"D Treppiedi","year":"2021","unstructured":"Treppiedi D, Di Muro G, Marra G et al (2021) USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs. Endocr Relat Cancer 28:573\u2013582. https:\/\/doi.org\/10.1530\/ERC-21-0093","journal-title":"Endocr Relat Cancer"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01220-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-022-01220-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01220-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T21:08:35Z","timestamp":1654549715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-022-01220-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1220"],"URL":"https:\/\/doi.org\/10.1007\/s11102-022-01220-4","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,22]]},"assertion":[{"value":"26 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None to be declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experiments were conducted in compliance with the protocol that was reviewed by the Research Ethics Committee and approved by the Ethics Committee of Kobe University Hospital (Approval Number: #1363), Toranomon Hospital (Approval Number: #252), and Moriyama Memorial Hospital (Approval Number: #20004).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Participants has been provided informed consent before the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent for publication were obtained from participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}